CRISPR Therapeutics
CRSP
#2967
Rank
S$5.85 B
Marketcap
$68.58
Share price
-0.50%
Change (1 day)
-5.21%
Change (1 year)

EPS for CRISPR Therapeutics (CRSP)

EPS in 2023 (TTM): -$7.32

According to CRISPR Therapeutics's latest financial reports the company's current EPS (TTM) is -$7.04. In 2022 the company made an earnings per share (EPS) of -$11.12 a decrease over its 2021 EPS that were of $6.63.

EPS history for CRISPR Therapeutics from 2016 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$7.32-34.22%
2022-$11.12-267.74%
2021$6.63-194.33%
2020-$7.03-576.58%
2019$1.47-132.36%
2018-$4.56100.58%
2017-$2.27159.42%
2016-$0.88

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$2.90-58.87%๐Ÿ‡บ๐Ÿ‡ธ USA